Despite the signaling differences between p190 and p210 Bcr-Abl isoforms have been investigated in cell line models, the knowledge of the differences between these isoforms in primary leukemia cells, especially in CML, is still in infancy. The gene discussed is EVPL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.